{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-010689","form_type":"8-K","ticker":"KWR","cik":"0000081362","company_name":"QUAKER CHEMICAL CORP","filed_at":"2026-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.758305+00:00","generated_at":"2026-05-16T01:19:39.321464+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Quaker Houghton reports Q4 net sales $468.5M (+6% Y/Y); FY2025 net loss $2.5M due to impairment","bullets":["Q4 net income $20.7M ($1.18 diluted EPS); non-GAAP EPS $1.65, up 24% Y/Y.","Full year net sales $1.89B; net loss $2.5M ($0.14 loss per share) includes $88.8M impairment and $35.1M restructuring.","Adjusted EBITDA Q4 $71.9M (+11% Y/Y); full year $299.2M.","Asia/Pacific segment net sales up 15% in Q4; Americas flat, EMEA up 7%.","Generated $136.5M operating cash flow in 2025; returned $75.9M to shareholders via dividends and buybacks."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-010689","json":"https://secwatch.observer/filing/0001628280-26-010689.json","markdown":"https://secwatch.observer/filing/0001628280-26-010689.md","text":"https://secwatch.observer/filing/0001628280-26-010689.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/81362/000162828026010689/0001628280-26-010689-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/81362/000162828026010689/kwr-20260223.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T01:19:39.321464+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}